FrançaisThe 20 best stocks of 2022 according to reliable analysts
These stocks were not cherry-picked in hindsight: they are the ones the method would have selected using only info known by end of 2021 (price targets from reliable analysts in the prior ~90 days), then held unchanged for 12 months. A true point-in-time record.
🎯 JPI Fair -13% · vs S&P 500 -20% · +6.8 pts
| # | Stock | 12-month return |
|---|---|---|
| 1 | COP ConocoPhillips | +64% |
| 2 | TMUS T-Mobile US | +21% |
| 3 | BIIB Biogen | +15% |
| 4 | ALL Allstate | +15% |
| 5 | INCY Incyte | +9% |
| 6 | ZBH Zimmer Biomet | +3% |
| 7 | PTC PTC Inc. | -1% |
| 8 | BA Boeing | -5% |
| 9 | TPR Tapestry, Inc. | -6% |
| 10 | UAL United Airlines Holdings | -14% |
| 11 | DAL Delta Air Lines | -16% |
| 12 | BBY Best Buy | -21% |
| 13 | LUV Southwest Airlines | -21% |
| 14 | IVZ Invesco | -22% |
| 15 | GPN Global Payments | -26% |
| 16 | MRNA Moderna | -29% |
| 17 | EBAY eBay Inc. | -38% |
| 18 | CRM Salesforce | -48% |
| 19 | PYPL PayPal | -62% |
| 20 | GNRC Generac | -71% |
⚡ JPI Risk + -8% · vs S&P 500 -20% · +11.2 pts
| # | Stock | 12-month return |
|---|---|---|
| 1 | OXY Occidental Petroleum | +117% |
| 2 | APA APA Corporation | +74% |
| 3 | VRTX Vertex Pharmaceuticals | +32% |
| 4 | LVS Las Vegas Sands | +28% |
| 5 | TMUS T-Mobile US | +21% |
| 6 | BIIB Biogen | +15% |
| 7 | WYNN Wynn Resorts | -3% |
| 8 | TPR Tapestry, Inc. | -6% |
| 9 | UAL United Airlines Holdings | -14% |
| 10 | DAL Delta Air Lines | -16% |
| 11 | BBY Best Buy | -21% |
| 12 | IP International Paper | -26% |
| 13 | GPN Global Payments | -26% |
| 14 | MRNA Moderna | -29% |
| 15 | ADSK Autodesk | -34% |
| 16 | NCLH Norwegian Cruise Line Holdings | -41% |
| 17 | GM General Motors | -43% |
| 18 | CCL Carnival Corporation | -60% |
| 19 | PYPL PayPal | -62% |
| 20 | GNRC Generac | -71% |
What if you'd kept following the method in 2023?
| Year | JPI Fair | S&P 500 |
|---|---|---|
| 2022 | -13% | -20% |
| 2023 | +48% | +24% |
| 2-year cumulative (if you kept going) | +29% | +0% |
💡 The takeaway — you have to accept the average or down years and stay in the method (sell, rebuy the newly recommended names). Whoever panics after a bad year misses the rebound. Discipline > emotion.
📊 See the full 11-year backtest → 🎯 Stocks to buy today →
FAQ
What were the best stocks to buy in 2022?
Per the JPI Fair method (targets from the ≥2 most reliable analysts per sector), the 20 S&P 500 stocks selected in early 2022 returned +-12.7% on average over 12 months, vs -19.5% for the index. The best was COP (ConocoPhillips) at +64%. See the full list above.
How were these 2022 stocks chosen?
With no hindsight: only from information known by end of 2021 (price targets from analysts with a real reliability track record on their sector), then held 12 months. A point-in-time backtest, not a hindsight pick.
Does this method actually work?
Over 11 years (2015-2025), the JPI Fair method returned +26%/yr vs +12.6% for the S&P 500 — double the market. But it's lumpy (drawdowns in 2018 and 2022) and risk-adjusted the edge is thinner. A quality signal, not a guarantee.
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational analysis, not investment advice. Point-in-time backtest on recomputed Yahoo data, universe = stocks still in the index (survivorship bias). Past performance does not predict the future.